Peru suspends China's Sinopharm COVID-19 vaccine trial

▴ Peru suspends China's Sinopharm COVID-19 vaccine trial
Peru suspended trials for China's Sinopharm COVID-19 vaccine due to a "serious adverse event" that occurred with one of the volunteers for the study, the Peruvian government said in a statement on Saturday.

German Malaga, chief researcher at the local Cayetano Heredia University, which is involved with the study, said one volunteer had experienced decreased strength in his legs, among other symptoms.

Malaga also said he was hopeful the suspension would lifted and the trial resume in a short period of time.

The health ministry said the event is "under investigation to determine if it is related to the vaccine or if there is another explanation."

Sinopharm Group Co Ltd, which is conducting its trials in Peru with some 12,000 volunteers, was about to complete the first stage of the trials in the next few days. Some 36,544 people have died so far in Peru from the coronavirus pandemic.

Back at home India steadily following the trend set over the past few weeks. Country's active caseload has fallen to 3.62% of the total active cases.

India has reported more daily recoveries than the daily new cases during the past 48 hours. The trend of more daily recoveries than the daily cases has led to a continuous contraction of India’s Active Caseload which presently stands at 3,56,546 yesterday.

While 30,254 persons in were found to be COVID positive in the country in the past 24 hours, 33,136 new recoveries were registered during the same period. This has led to a net decline of 3,273 cases from the total Active Caseload in the last 24 hours.

Tags : #Peru #LatestCOVIDNews14thDec #LatestCOVIDVaccineNews14thDec #Sinopharm #China #India #ActiveCaseload #IndiaFightsCorona #Unite2FightCorona

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

FDA Confirms Bird Flu Virus Remnants in Pasteurized Milk: Safety and Regulatory InsightsApril 24, 2024
Sarvodaya Hospital Redefines Total Knee Replacement Surgery with Augmented Reality April 23, 2024
Fateh Education announces partnership to expand educational opportunities for Indian studentsApril 23, 2024
10 Strategies to counter disinformation for the healthcare digital ecosystemApril 23, 2024
Is Selling Over-the-Counter (OTC) Drugs in General Stores A Step Towards Affordable Healthcare in IndiaApril 23, 2024
Student Health Crisis: Food Poisoning Incident Strikes Pune Coaching CentreApril 23, 2024
The Impact of Diabetes on Kidney Health: Diabetic Nephropathy ExplainedApril 23, 2024
Toddler Hospitalized After Consuming Expired Chocolates: Health Concerns RaisedApril 23, 2024
After months of diagnostic delay, a migrant worker could access TB services only when a community health worker met himApril 22, 2024
Indian Spices Contaminated with Cancer-Causing Chemical: Hong Kong Food Regulators Issue WarningApril 22, 2024
FTCCI organised a Workshop on Rooftop Kitchen GardeningApril 20, 2024
Children in Cities Exposed to Elevated Lead Levels: Study Reveals Urgent Health ConcernApril 20, 2024
Biocon Ventures into Weight-Loss Drug Market with Semaglutide DevelopmentApril 20, 2024
Innovative AI Assistance Empowers Moscow Doctors to Detect Cervical Spine Issues through MRI ScansApril 20, 2024
Air India Express ties up with AISATS for AeroWash Automated Aircraft Exterior Cleanings April 19, 2024
IndoSup raises strategic funding led by CCI group promoters Naresh Sharma and Satish Sharma; investors include Yatra.com’s Rohan Mittal April 19, 2024
10 compelling reasons why choosing right media platform Is important in healthcareApril 19, 2024
Protecting Public Health: Proposed Guidelines for Pharmaceutical Product DistributionApril 19, 2024
What is Haemophilia: A Genetic Bleeding Disorder that has Affected 1,36,000 IndiansApril 19, 2024
Climate Change and Stroke Risk: Exploring the Impact of Temperature Fluctuations on Your Body April 19, 2024